Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 0.2% QD vs Olopatadine Hydrochloride Ophthalmic Solution 0.1% BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects

NCT02322216 is registered in ClinicalTrials.gov with Alcon Research as lead sponsor.

NCT NCT02322216
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02322216 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Comparative Study of Olopatadine Hydrochloride Ophthalmic Solution 0.2% QD vs Olopatadine Hydrochloride Ophthalmic Solution 0.1% BID in the Treatment of Allergic Conjunctivitis in Chinese Subjects
Lead sponsor
Alcon Research
Phase
Phase 3
Overall status
Completed
Start date
December 31, 2014
Completion date
October 31, 2015
Enrollment
383 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis